{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:51:32Z","timestamp":1787770292516,"version":"build-2784847793"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-022-01916-4","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T13:02:50Z","timestamp":1670245370000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Medicinal chemistry aspects and synthetic strategies of coumarin as aromatase inhibitors: an overview"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3542-2943","authenticated-orcid":false,"given":"Pooja","family":"Ratre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0237-3826","authenticated-orcid":false,"given":"Swanand","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9321-9030","authenticated-orcid":false,"given":"Sweety","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7360-8998","authenticated-orcid":false,"given":"Chengyuan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0795-2819","authenticated-orcid":false,"given":"Pradyumna Kumar","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7668-462X","authenticated-orcid":false,"given":"Suresh","family":"Thareja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,5]]},"reference":[{"key":"1916_CR1","unstructured":"World Health Organization. 2022. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/breast-cancer. Accessed 02 Aug 2022."},{"issue":"5","key":"1916_CR2","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1634\/theoncologist.2015-0464","volume":"22","author":"VG Kaklamani","year":"2017","unstructured":"Kaklamani VG, Gradishar WJ. Endocrine therapy in the current management of postmenopausal estrogen receptor-positive metastatic breast cancer. Oncologist. 2017;22(5):507\u201317.","journal-title":"Oncologist"},{"key":"1916_CR3","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.bbacli.2017.01.001","volume":"7","author":"KE Lukong","year":"2017","unstructured":"Lukong KE. Understanding breast cancer\u2013the long and winding road. BBA clinical. 2017;7:64\u201377.","journal-title":"BBA clinical"},{"issue":"3","key":"1916_CR4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s12672-016-0259-0","volume":"7","author":"CP Capper","year":"2016","unstructured":"Capper CP, Rae JM, Auchus RJ. The metabolism, analysis, and targeting of steroid hormones in breast and prostate cancer. Horm Cancer. 2016;7(3):149\u201364.","journal-title":"Horm Cancer"},{"issue":"1","key":"1916_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nrurol.2010.207","volume":"8","author":"CK Ho","year":"2011","unstructured":"Ho CK, Habib FK. Estrogen and androgen signaling in the pathogenesis of BPH. Nat Rev Urol. 2011;8(1):29\u201341.","journal-title":"Nat Rev Urol"},{"issue":"17","key":"1916_CR6","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.2174\/1871520620666200627204105","volume":"20","author":"P Ratre","year":"2020","unstructured":"Ratre P, Mishra K, Dubey A, Vyas A, Jain A, Thareja S. Aromatase inhibitors for the treatment of breast cancer: a journey from the scratch. AntiCancer Agents Med Chem. 2020;20(17):1994\u20132004.","journal-title":"AntiCancer Agents Med Chem"},{"key":"1916_CR7","doi-asserted-by":"publisher","first-page":"493","DOI":"10.2147\/IJWH.S69907","volume":"7","author":"S Chumsri","year":"2015","unstructured":"Chumsri S. Clinical utilities of aromatase inhibitors in breast cancer. Int J Women\u2019s Health. 2015;7:493.","journal-title":"Int J Women's Health"},{"issue":"10023","key":"1916_CR8","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0140-6736(15)00130-0","volume":"387","author":"P Morice","year":"2016","unstructured":"Morice P, Leary A, Creutzberg C, Abu-Rustum N, Darai E. Endometrial cancer. The Lancet. 2016;387(10023):1094\u2013108.","journal-title":"The Lancet"},{"key":"1916_CR9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1159\/000494909","volume":"53","author":"EK Kostakis","year":"2019","unstructured":"Kostakis EK, Gkioni LN, Macut D, Mastorakos G. Androgens in menopausal women not only polycystic ovary syndrome. Hyperandrogenism in Women. 2019;53:135\u201361.","journal-title":"Hyperandrogenism in Women."},{"issue":"3","key":"1916_CR10","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.molmed.2012.12.007","volume":"19","author":"J Cui","year":"2013","unstructured":"Cui J, Shen Y, Li R. Estrogen synthesis and signaling pathways during aging: from periphery to brain. Trends Mol Med. 2013;19(3):197\u2013209.","journal-title":"Trends Mol Med"},{"key":"1916_CR11","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3389\/fimmu.2019.00348","volume":"10","author":"M Segovia-Mendoza","year":"2019","unstructured":"Segovia-Mendoza M, Morales-Montor J. Immune tumor microenvironment in breast cancer and the participation of estrogen and its receptors in cancer physiopathology. Front Immunol. 2019;10:348.","journal-title":"Front Immunol"},{"key":"1916_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.mce.2017.09.014","volume":"466","author":"C Gerard","year":"2018","unstructured":"Gerard C, Brown KA. Obesity and breast cancer\u2013role of estrogens and the molecular underpinnings of aromatase regulation in breast adipose tissue. Mol Cell Endocrinol. 2018;466:15\u201330.","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"1916_CR13","doi-asserted-by":"publisher","first-page":"R19","DOI":"10.1530\/JME-15-0310","volume":"57","author":"H Zhao","year":"2016","unstructured":"Zhao H, Zhou L, Shangguan AJ, Bulun SE. Aromatase expression and regulation in breast and endometrial cancer. J Mol Endocrinol. 2016;57(1):R19.","journal-title":"J Mol Endocrinol"},{"issue":"22","key":"1916_CR14","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.2174\/1385272824999200709125717","volume":"24","author":"G Patel","year":"2020","unstructured":"Patel G, Banerjee S. Review on synthesis of bio-active coumarin-fused heterocyclic molecules. Curr Org Chem. 2020;24(22):2566\u201387.","journal-title":"Curr Org Chem"},{"issue":"10","key":"1916_CR15","doi-asserted-by":"publisher","first-page":"4121","DOI":"10.1016\/j.ejmech.2009.05.003","volume":"44","author":"Marco A.C. Neves","year":"2009","unstructured":"Neves Marco A.C., Dinis Teresa C.P., Giorgio Colombo M, S\u00e1 e Melo Luisa. An efficient steroid pharmacophore-based strategy to identify new aromatase inhibitors. Eur J Med Chem. 2009;44(10):4121\u20137.","journal-title":"Eur J Med Chem"},{"issue":"6","key":"1916_CR16","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1002\/ajoc.202100181","volume":"10","author":"A Biswas","year":"2021","unstructured":"Biswas A, Ghosh A, Shankhdhar R, Chatterjee I. Squaramide catalyzed asymmetric synthesis of five-and six-membered rings. Asian J Org Chem. 2021;10(6):1345\u201376.","journal-title":"Asian J Org Chem"},{"issue":"32","key":"1916_CR17","doi-asserted-by":"publisher","first-page":"4236","DOI":"10.2174\/092986709789578187","volume":"16","author":"L Wu","year":"2009","unstructured":"Wu L, Wang X, Xu W, Farzaneh F, Xu R. The structure and pharmacological functions of coumarins and their derivatives. Curr Med Chem. 2009;16(32):4236\u201360.","journal-title":"Curr Med Chem"},{"key":"1916_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s11244-022-01571-z","author":"VM Adimule","year":"2022","unstructured":"Adimule VM, Nandi SS, Kerur S, Khadapure SA, Chinnam S. Recent advances in the one-pot synthesis of coumarin derivatives from different starting materials using nanoparticles: a review. Top Catal. 2022. https:\/\/doi.org\/10.1007\/s11244-022-01571-z.","journal-title":"Top Catal"},{"issue":"11","key":"1916_CR19","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.3390\/plants9111582","volume":"9","author":"DN Shurpik","year":"2020","unstructured":"Shurpik DN, Akhmedov AA, Cragg PJ, Plemenkov VV, Stoikov II. Progress in the chemistry of macrocyclic meroterpenoids. Plants. 2020;9(11):1582.","journal-title":"Plants"},{"key":"1916_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-13-7154-7","volume-title":"Natural bio-active compounds","author":"MS Akhtar","year":"2019","unstructured":"Akhtar MS, Swamy MK, Sinniah UR. Natural bio-active compounds. Singapore: Springer; 2019."},{"issue":"7","key":"1916_CR21","doi-asserted-by":"publisher","first-page":"863","DOI":"10.2478\/s11756-019-00242-x","volume":"74","author":"MI Hussain","year":"2019","unstructured":"Hussain MI, Syed QA, Khattak MNK, Hafez B, Reigosa MJ, El-Keblawy A. Natural product coumarins: biological and pharmacological perspectives. Biologia. 2019;74(7):863\u201388.","journal-title":"Biologia"},{"key":"1916_CR22","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3389\/fchem.2020.00623","volume":"8","author":"V Raj","year":"2020","unstructured":"Raj V, Lee J. 2H\/4H-chromenes\u2014a versatile biologically attractive scaffold. Front Chem. 2020;8:623.","journal-title":"Front Chem"},{"issue":"2","key":"1916_CR23","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3390\/molecules23020250","volume":"23","author":"A Stefanachi","year":"2018","unstructured":"Stefanachi A, Leonetti F, Pisani L, Catto M, Carotti A. Coumarin: a natural, privileged and versatile scaffold for bioactive compounds. Molecules. 2018;23(2):250.","journal-title":"Molecules"},{"issue":"3","key":"1916_CR24","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1021\/acs.orglett.7b03859","volume":"20","author":"SI Fa\u00dfbender","year":"2018","unstructured":"Fa\u00dfbender SI, Metternich JB, Gilmour R. Spatiotemporal control of pre-existing alkene geometry: a bio-inspired route to 4-trifluoromethyl-2 H-chromenes. Org Lett. 2018;20(3):724\u20137.","journal-title":"Org Lett"},{"issue":"8","key":"1916_CR25","doi-asserted-by":"publisher","first-page":"2000025","DOI":"10.1002\/ardp.202000025","volume":"353","author":"XF Song","year":"2020","unstructured":"Song XF, Fan J, Liu L, Liu XF, Gao F. Coumarin derivatives with anticancer activities: an update. Arch Pharm. 2020;353(8):2000025.","journal-title":"Arch Pharm"},{"issue":"12","key":"1916_CR26","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.2174\/1389557516666160624123425","volume":"17","author":"Takayuki Tohge","year":"2017","unstructured":"Tohge Takayuki, Fernie Alisdair R. An overview of compounds derived from the shikimate and phenylpropanoid pathways and their medicinal importance. Mini Rev Med Chem. 2017;17(12):1013\u201327.","journal-title":"Mini Rev Med Chem"},{"issue":"1","key":"1916_CR27","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s11103-017-0650-4","volume":"95","author":"R Yao","year":"2017","unstructured":"Yao R, Zhao Y, Liu T, Huang C, Xu S, Sui Z, et al. Identification and functional characterization of a p-coumaroyl CoA 2\u2032-hydroxylase involved in the biosynthesis of coumarin skeleton from peucedanum praeruptorum dunn. Plant Mol Biol. 2017;95(1):199\u2013213.","journal-title":"Plant Mol Biol"},{"issue":"3","key":"1916_CR28","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1021\/jo9712198","volume":"63","author":"S Chang","year":"1998","unstructured":"Chang S, Grubbs RH. A highly efficient and practical synthesis of chromene derivatives using ring-closing olefin metathesis. J Org Chem. 1998;63(3):864\u20136.","journal-title":"J Org Chem"},{"issue":"1","key":"1916_CR29","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.3762\/bjoc.8.244","volume":"8","author":"IB Masesane","year":"2012","unstructured":"Masesane IB, Desta ZY. Reactions of salicylaldehyde and enolates or their equivalents: versatile synthetic routes to chromane derivatives. Beilstein J Org Chem. 2012;8(1):2166\u201375.","journal-title":"Beilstein J Org Chem"},{"issue":"1","key":"1916_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2008-2231-21-31","volume":"21","author":"S Noushini","year":"2013","unstructured":"Noushini S, Alipour E, Emami S, Safavi M, Ardestani SK, Gohari AR, et al. Synthesis and cytotoxic properties of novel (E)-3-benzylidene-7-methoxychroman-4-one derivatives. DARU J Pharm Sci. 2013;21(1):1\u201310.","journal-title":"DARU J Pharm Sci"},{"issue":"21","key":"1916_CR31","doi-asserted-by":"publisher","first-page":"13858","DOI":"10.1021\/acs.joc.9b02036","volume":"84","author":"K Tanaka","year":"2019","unstructured":"Tanaka K, Kishimoto M, Asada Y, Tanaka Y, Hoshino Y, Honda K. Access to electron-deficient 2, 2-disubstituted chromanes: a highly regioselective one-pot synthesis via an inverse-electron-demand [4+ 2] cycloaddition of ortho-quinone methides. J Org Chem. 2019;84(21):13858\u201370.","journal-title":"J Org Chem"},{"issue":"8","key":"1916_CR32","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.5012\/bkcs.2004.25.8.1123","volume":"25","author":"J-H Cha","year":"2004","unstructured":"Cha J-H, Cho Y-S, Koh H-Y, Lee E, Kim Y-T, Yang H-H, et al. Preparation of chromane derivatives via indium-mediated intramolecular allylation reactions. Bull Korean Chem Soc. 2004;25(8):1123\u20134.","journal-title":"Bull Korean Chem Soc"},{"issue":"34","key":"1916_CR33","doi-asserted-by":"publisher","first-page":"6347","DOI":"10.1016\/S0040-4039(00)73429-0","volume":"35","author":"AR Rao","year":"1994","unstructured":"Rao AR, Gaitonde A, Prakash K, Rao SP. A concise synthesis of chiral 2-methyl chroman-4-ones: stereo selective build-up of the chromanol moiety of anti-hiv agent calanolide A. Tetrahedron Lett. 1994;35(34):6347\u201350.","journal-title":"Tetrahedron Lett"},{"issue":"1","key":"1916_CR34","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1039\/C8OB02677G","volume":"17","author":"S Jakkampudi","year":"2019","unstructured":"Jakkampudi S, Parella R, Zhao JC-G. Stereoselective synthesis of chromane derivatives via a domino reaction catalyzed by modularly designed organocatalysts. Org Biomol Chem. 2019;17(1):151\u20135.","journal-title":"Org Biomol Chem"},{"issue":"9","key":"1916_CR35","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1002\/jhet.4054","volume":"57","author":"NP Kapuriya","year":"2020","unstructured":"Kapuriya NP, Bhalodia JJ, Ambasana MA, Patel RB, Bapodra AH. Organocatalyzed kabbe condensation reaction for mild and expeditious synthesis of 2, 2-dialkyl and 2-spiro-4-chromanones. J Heterocycl Chem. 2020;57(9):3369\u201374.","journal-title":"J Heterocycl Chem"},{"issue":"1","key":"1916_CR36","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.bmc.2013.11.045","volume":"22","author":"E Amato","year":"2014","unstructured":"Amato E, Bankemper T, Kidney R, Do T, Onate A, Thowfeik FS, et al. Investigation of fluorinated and bifunctionalized 3-phenylchroman-4-one (isoflavanone) aromatase inhibitors. Bioorg Med Chem. 2014;22(1):126\u201334.","journal-title":"Bioorg Med Chem"},{"issue":"1","key":"1916_CR37","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1039\/C7QO00768J","volume":"5","author":"S Ruan","year":"2018","unstructured":"Ruan S, Lin X, Xie L, Lin L, Feng X, Liu X. Asymmetric synthesis of 3-aminodihydrocoumarins via the chiral guanidine catalyzed cascade reaction of azlactones. Org Chem Front. 2018;5(1):32\u20135.","journal-title":"Org Chem Front"},{"issue":"6","key":"1916_CR38","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1039\/C7RA13525D","volume":"8","author":"C-K Tang","year":"2018","unstructured":"Tang C-K, Feng K-X, Xia A-B, Li C, Zheng Y-Y, Xu Z-Y, et al. Asymmetric synthesis of polysubstituted chiral chromans via an organocatalytic oxa-michael-nitro-michael domino reaction. RSC Adv. 2018;8(6):3095\u20138.","journal-title":"RSC Adv"},{"issue":"16","key":"1916_CR39","doi-asserted-by":"publisher","first-page":"7104","DOI":"10.1021\/jm3005288","volume":"55","author":"Maria Frid\u00e9n-Saxin","year":"2012","unstructured":"Frid\u00e9n-Saxin Maria, Seifert Tina, Landergren Marie Ryd\u00e9n, Suuronen Tiina, Lahtela-Kakkonen Maija, Jarho Elina M, Luthman Kristina. Synthesis and evaluation of substituted chroman-4-one and chromone derivatives as sirtuin 2-selective inhibitors. J Med Chem. 2012;55(16):7104\u201313.","journal-title":"J Med Chem"},{"issue":"48","key":"1916_CR40","doi-asserted-by":"publisher","first-page":"9641","DOI":"10.1016\/j.tet.2003.09.095","volume":"59","author":"O Roy","year":"2003","unstructured":"Roy O, Loiseau F, Riahi A, H\u00e9nin F, Muzart J. Access to racemic and enantioenriched 3-methyl-4-chromanones: catalysed asymmetric protonation of corresponding enolic species as the key step. Tetrahedron. 2003;59(48):9641\u20138.","journal-title":"Tetrahedron"},{"issue":"24","key":"1916_CR41","doi-asserted-by":"publisher","first-page":"6480","DOI":"10.1021\/ol202772k","volume":"13","author":"Y Luan","year":"2011","unstructured":"Luan Y, Sun H, Schaus SE. Iron-catalyzed rearrangements and cycloaddition reactions of 2 H-chromenes. Org Lett. 2011;13(24):6480\u20133.","journal-title":"Org Lett"},{"issue":"7","key":"1916_CR42","doi-asserted-by":"publisher","first-page":"4221","DOI":"10.1021\/acs.joc.8b00234","volume":"83","author":"L Cui","year":"2018","unstructured":"Cui L, Lv D, Wang Y, Fan Z, Li Z, Zhou Z. Asymmetric formal [4+ 2] annulation of o-quinone methides with \u03b2-keto acylpyrazoles: a general approach to optically active trans-3, 4-dihydrocoumarins. J Org Chem. 2018;83(7):4221\u20138.","journal-title":"J Org Chem"},{"issue":"18","key":"1916_CR43","doi-asserted-by":"publisher","first-page":"4936","DOI":"10.1002\/anie.201612149","volume":"56","author":"Y Xie","year":"2017","unstructured":"Xie Y, List B. Catalytic asymmetric intramolecular [4+ 2] cycloaddition of in situ generated ortho-quinone methides. Angew Chem Int Ed. 2017;56(18):4936\u201340.","journal-title":"Angew Chem Int Ed"},{"issue":"23","key":"1916_CR44","doi-asserted-by":"publisher","first-page":"3604","DOI":"10.1055\/s-0040-1707209","volume":"52","author":"VA Osyanin","year":"2020","unstructured":"Osyanin VA, Osipov DV, Melnikova IV, Korzhenko KS, Semenova IA, Klimochkin YN. Catalyst-free synthesis of chromane-type N, O-acetals via intramolecular addition of phenols to enamines. Synthesis. 2020;52(23):3604\u201321.","journal-title":"Synthesis"},{"issue":"38","key":"1916_CR45","doi-asserted-by":"publisher","first-page":"4824","DOI":"10.1016\/j.tetlet.2011.07.018","volume":"52","author":"Y-L Zhong","year":"2011","unstructured":"Zhong Y-L, Boruta DT, Gauthier DR Jr, Askin D. An efficient synthesis of 4-chromanones. Tetrahedron Lett. 2011;52(38):4824\u20136.","journal-title":"Tetrahedron Lett"},{"issue":"13","key":"1916_CR46","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1016\/j.tet.2013.01.078","volume":"69","author":"AV Dubrovskiy","year":"2013","unstructured":"Dubrovskiy AV, Larock RC. Intermolecular C-O addition of carboxylic acids to arynes: synthesis of o-hydroxyaryl ketones, xanthones, 4-chromanones, and flavones. Tetrahedron. 2013;69(13):2789\u201398.","journal-title":"Tetrahedron"},{"key":"1916_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-803797-3.00001-1","volume-title":"Introduction to Coumarin and SAR. Advances in Structure and Activity Relationship of Coumarin Derivatives","author":"S Penta","year":"2016","unstructured":"Penta S. Introduction to Coumarin and SAR. Advances in Structure and Activity Relationship of Coumarin Derivatives. Amsterdam: Elsevier; 2016. p. 1\u20138."},{"key":"1916_CR48","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ejmech.2016.03.087","volume":"119","author":"J Dandriyal","year":"2016","unstructured":"Dandriyal J, Singla R, Kumar M, Jaitak V. Recent developments of C-4 substituted coumarin derivatives as anticancer agents. Eur J Med Chem. 2016;119:141\u201368.","journal-title":"Eur J Med Chem"},{"issue":"1","key":"1916_CR49","doi-asserted-by":"publisher","first-page":"20","DOI":"10.2174\/1573408016666200325120248","volume":"16","author":"S Makar","year":"2020","unstructured":"Makar S, Ghosh A, Kumar A, Singh SK. Recent studies on aromatase and sulfatase involved in breast cancer and their inhibitors. Curr Enzym Inhib. 2020;16(1):20\u201344.","journal-title":"Curr Enzym Inhib"},{"key":"1916_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2021.104865","volume":"112","author":"S Chitti","year":"2021","unstructured":"Chitti S, Pulya S, Nandikolla A, Patel TK, Kumar BK, Murugesan S, et al. Design, synthesis and biological evaluation of 7\u2013(5\u2013((substituted\u2013amino)-methyl)-thiophen\u20132\u2013yl)-spiro-[chroman\u20132, 4\u2032\u2013piperidin]\u20134\u2013one hydrochloride analogues as anticancer agents. Bioorg Chem. 2021;112: 104865.","journal-title":"Bioorg Chem"},{"issue":"1","key":"1916_CR51","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s10549-020-05829-6","volume":"184","author":"CL Braal","year":"2020","unstructured":"Braal CL, Hussaarts KG, Seuren L, Oomen-de Hoop E, de Bruijn P, Buck SA, et al. Influence of green tea consumption on endoxifen steady-state concentration in breast cancer patients treated with tamoxifen. Breast Cancer Res Treat. 2020;184(1):107\u201313.","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"1916_CR52","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.3390\/ijms21051744","volume":"21","author":"C Musial","year":"2020","unstructured":"Musial C, Kuban-Jankowska A, Gorska-Ponikowska M. Beneficial properties of green tea catechins. Int J Mol Sci. 2020;21(5):1744.","journal-title":"Int J Mol Sci"},{"key":"1916_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119449","volume":"585","author":"J Kazi","year":"2020","unstructured":"Kazi J, Sen R, Ganguly S, Jha T, Ganguly S, Debnath MC. Folate decorated epigallocatechin-3-gallate (EGCG) loaded PLGA nanoparticles; in-vitro and in-vivo targeting efficacy against MDA-MB-231 tumor xenograft. Int J Pharm. 2020;585: 119449.","journal-title":"Int J Pharm"},{"key":"1916_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2019.111939","volume":"187","author":"D Dupommier","year":"2020","unstructured":"Dupommier D, Muller C, Comoy C, Mazerbourg S, Bordessa A, Piquard E, et al. New desulfured troglitazone derivatives: improved synthesis and biological evaluation. Eur J Med Chem. 2020;187: 111939.","journal-title":"Eur J Med Chem"},{"key":"1916_CR55","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/2069250","author":"DS Dimi\u0107","year":"2019","unstructured":"Dimi\u0107 DS, Markovi\u0107 ZS, Saso L, Avdovi\u0107 EH, \u0110orovi\u0107 JR, Petrovi\u0107 IP, et al. Synthesis and characterization of 3-(1-((3, 4-dihydroxyphenethyl) amino) ethylidene)-chroman-2, 4-dione as a potential antitumor agent. Oxid Med Cell Longev. 2019. https:\/\/doi.org\/10.1155\/2019\/2069250.","journal-title":"Oxid Med Cell Longev"},{"key":"1916_CR56","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.phymed.2018.09.216","volume":"52","author":"M Dong","year":"2019","unstructured":"Dong M, Ye T, Bi Y, Wang Q, Kuerban K, Li J, et al. A novel hybrid of 3-benzyl coumarin seco-b-ring derivative and phenylsulfonylfuroxan induces apoptosis and autophagy in non-small-cell lung cancer. Phytomedicine. 2019;52:79\u201388.","journal-title":"Phytomedicine"},{"issue":"6","key":"1916_CR57","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.3390\/molecules24061027","volume":"24","author":"A Gir\u00f3-Perafita","year":"2019","unstructured":"Gir\u00f3-Perafita A, Rabionet M, Planas M, Feliu L, Ciurana J, Ruiz-Mart\u00ednez S, et al. EGCG-Derivative G28 shows high efficacy inhibiting the mammosphere-forming capacity of sensitive and resistant TNBC models. Molecules. 2019;24(6):1027.","journal-title":"Molecules"},{"issue":"01","key":"1916_CR58","first-page":"009","volume":"8","author":"SA Abdelatef","year":"2018","unstructured":"Abdelatef SA, El-Saadi MT, Amin NH, Abdelazeem AH, Abdellatif KR. Synthesis and anticancer screening of novel spiro [chromaffin-2, 4\u2032-piperidin]-4-one derivatives with apoptosis-inducing activity. J Appl Pharm Sci. 2018;8(01):009\u201316.","journal-title":"J Appl Pharm Sci"},{"issue":"6","key":"1916_CR59","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.jsps.2017.02.003","volume":"25","author":"SA Morsy","year":"2017","unstructured":"Morsy SA, Farahat AA, Nasr MN, Tantawy AS. Synthesis, molecular modeling and anticancer activity of new coumarin containing compounds. Saudi Pharm J. 2017;25(6):873\u201383.","journal-title":"Saudi Pharm J"},{"issue":"12","key":"1916_CR60","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1016\/j.bmcl.2017.01.062","volume":"27","author":"Y Yamaguchi","year":"2017","unstructured":"Yamaguchi Y, Nishizono N, Kobayashi D, Yoshimura T, Wada K, Oda K. Evaluation of synthesized coumarin derivatives on aromatase inhibitory activity. Bioorg Med Chem Lett. 2017;27(12):2645\u20139.","journal-title":"Bioorg Med Chem Lett"},{"issue":"3","key":"1916_CR61","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.bmcl.2013.12.095","volume":"24","author":"W Zhang","year":"2014","unstructured":"Zhang W, Li Z, Zhou M, Wu F, Hou X, Luo H, et al. Synthesis and biological evaluation of 4-(1, 2, 3-triazol-1-yl) coumarin derivatives as potential antitumor agents. Bioorg Med Chem Lett. 2014;24(3):799\u2013807.","journal-title":"Bioorg Med Chem Lett"},{"key":"1916_CR62","doi-asserted-by":"publisher","first-page":"S2443","DOI":"10.1016\/j.arabjc.2013.09.008","volume":"10","author":"N Kumar","year":"2017","unstructured":"Kumar N, Bhatnagar A, Dudhe R. Synthesis of 3-(4, 5-dihydro-1-phenyl-5-substituted phenyl-1h-pyrazol-3-yl)-2h-chromen-2-one derivatives and evaluation of their anticancer activity. Arab J Chem. 2017;10:S2443\u201352.","journal-title":"Arab J Chem"},{"issue":"7","key":"1916_CR63","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.jsps.2017.04.040","volume":"25","author":"S Demirayak","year":"2017","unstructured":"Demirayak S, Yurttas L, Gundogdu-Karaburun N, Karaburun AC, Kayagil I. New chroman-4-one\/thiochroman-4-one derivatives as potential anticancer agents. Saudi Pharm J. 2017;25(7):1063\u201372.","journal-title":"Saudi Pharm J"},{"issue":"17","key":"1916_CR64","doi-asserted-by":"publisher","first-page":"8828","DOI":"10.1039\/C3RA45749D","volume":"4","author":"MK Hussain","year":"2014","unstructured":"Hussain MK, Ansari MI, Yadav N, Gupta PK, Gupta AK, Saxena R, et al. Design and synthesis of ER\u03b1\/ER\u03b2 selective coumarin and chromene derivatives as potential anti-breast cancer and anti-osteoporotic agents. RSC Adv. 2014;4(17):8828\u201345.","journal-title":"RSC Adv"},{"key":"1916_CR65","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ejmech.2012.11.044","volume":"60","author":"KV Sashidhara","year":"2013","unstructured":"Sashidhara KV, Avula SR, Sharma K, Palnati GR, Bathula SR. Discovery of coumarin\u2013monastrol hybrid as potential antibreast tumor-specific agent. Eur J Med Chem. 2013;60:120\u20137.","journal-title":"Eur J Med Chem"},{"issue":"12","key":"1916_CR66","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.1016\/j.bmcl.2012.12.071","volume":"23","author":"K Paul","year":"2013","unstructured":"Paul K, Bindal S, Luxami V. Synthesis of new conjugated coumarin\u2013benzimidazole hybrids and their anticancer activity. Bioorg Med Chem Lett. 2013;23(12):3667\u201372.","journal-title":"Bioorg Med Chem Lett"},{"issue":"8","key":"1916_CR67","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1016\/j.bmc.2012.02.042","volume":"20","author":"K Bonfield","year":"2012","unstructured":"Bonfield K, Amato E, Bankemper T, Agard H, Steller J, Keeler JM, et al. Development of a new class of aromatase inhibitors: design, synthesis and inhibitory activity of 3-phenylchroman-4-one (isoflavanone) derivatives. Bioorg Med Chem. 2012;20(8):2603\u201313.","journal-title":"Bioorg Med Chem"},{"issue":"4","key":"1916_CR68","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1021\/ml300018e","volume":"3","author":"H Zhao","year":"2012","unstructured":"Zhao H, Yan B, Peterson LB, Blagg BS. 3-Arylcoumarin derivatives manifest anti-proliferative activity through Hsp90 inhibition. ACS Med Chem Lett. 2012;3(4):327\u201331.","journal-title":"ACS Med Chem Lett"},{"issue":"23","key":"1916_CR69","doi-asserted-by":"publisher","first-page":"7127","DOI":"10.1016\/j.bmcl.2010.09.040","volume":"20","author":"KV Sashidhara","year":"2010","unstructured":"Sashidhara KV, Rosaiah JN, Kumar M, Gara RK, Nayak LV, Srivastava K, et al. Neo-tanshinlactone inspired synthesis, in vitro evaluation of novel substituted benzocoumarin derivatives as potent anti-breast cancer agents. Bioorg Med Chem Lett. 2010;20(23):7127\u201331.","journal-title":"Bioorg Med Chem Lett"},{"issue":"9","key":"1916_CR70","doi-asserted-by":"publisher","first-page":"399","DOI":"10.6026\/97320630003399","volume":"3","author":"KS Hatti","year":"2009","unstructured":"Hatti KS, Diwakar L, Rao GV, Kush A, Reddy GC. Abyssinones and related flavonoids as potential steroidogenesis modulators. Bioinformation. 2009;3(9):399.","journal-title":"Bioinformation"},{"issue":"2","key":"1916_CR71","doi-asserted-by":"publisher","first-page":"176","DOI":"10.52711\/0974-4150.2022.00030","volume":"15","author":"K Beena","year":"2022","unstructured":"Beena K, Pooja GS. A review on pyranocoumarins and its biological importance. Asian J Res Chem. 2022;15(2):176\u201381.","journal-title":"Asian J Res Chem"},{"issue":"27","key":"1916_CR72","doi-asserted-by":"publisher","first-page":"6792","DOI":"10.1021\/jm049535j","volume":"47","author":"F Leonetti","year":"2004","unstructured":"Leonetti F, Favia A, Rao A, Aliano R, Paluszcak A, Hartmann RW, et al. Design, synthesis, and 3D QSAR of novel potent and selective aromatase inhibitors. J Med Chem. 2004;47(27):6792\u2013803.","journal-title":"J Med Chem"},{"issue":"46","key":"1916_CR73","doi-asserted-by":"publisher","first-page":"48071","DOI":"10.1074\/jbc.M406847200","volume":"279","author":"S Chen","year":"2004","unstructured":"Chen S, Cho M, Karlsberg K, Zhou D, Yuan Y-C. Biochemical and biological characterization of a novel anti-aromatase coumarin derivative. J Biol Chem. 2004;279(46):48071\u20138.","journal-title":"J Biol Chem"},{"issue":"3","key":"1916_CR74","doi-asserted-by":"publisher","first-page":"269","DOI":"10.2131\/jts.33.269","volume":"33","author":"T Nakanishi","year":"2008","unstructured":"Nakanishi T. Endocrine disruption induced by organotin compounds; organotins function as a powerful agonist for nuclear receptors rather than an aromatase inhibitor. J Toxicol Sci. 2008;33(3):269\u201376.","journal-title":"J Toxicol Sci"},{"issue":"8","key":"1916_CR75","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1210\/endo.143.8.8932","volume":"143","author":"GL Rubin","year":"2002","unstructured":"Rubin GL, Duong JH, Clyne CD, Speed CJ, Murata Y, Gong C, et al. Ligands for the peroxisomal proliferator-activated receptor \u03b3 and the retinoid X receptor inhibit aromatase cytochrome P450 (CYP19) expression mediated by promoter II in human breast adipose. Endocrinology. 2002;143(8):2863\u201371.","journal-title":"Endocrinology"},{"issue":"19","key":"1916_CR76","doi-asserted-by":"publisher","first-page":"11233","DOI":"10.3390\/ijms231911233","volume":"23","author":"F Luo","year":"2022","unstructured":"Luo F, Manse Y, Chaipech S, Pongpiriyadacha Y, Muraoka O, Morikawa T. Phytochemicals with chemopreventive activity obtained from the thai medicinal plant mammea siamensis (Miq) T. Anders.: isolation and structure determination of new prenylcoumarins with inhibitory activity against aromatase. Int J Mol Sci. 2022;23(19):11233.","journal-title":"Int J Mol Sci"},{"key":"1916_CR77","doi-asserted-by":"crossref","unstructured":"Kurt BZ, Kandas NO, Dag A, Sonmez F, Kucukislamoglu M. Synthesis and biological evaluation of novel coumarin-chalcone derivatives containing urea moiety as potential anticancer agents. Arab J Chem. 2020;13:1120\u20131129.","DOI":"10.1016\/j.arabjc.2017.10.001"},{"issue":"19","key":"1916_CR78","doi-asserted-by":"publisher","first-page":"4578","DOI":"10.1016\/j.bmcl.2017.08.044","volume":"27","author":"N Lv","year":"2017","unstructured":"Lv N, Sun M, Liu C, Li J. Design and synthesis of 2-phenylpyrimidine coumarin derivatives as anticancer agents. Bioorg Med Chem Lett. 2017;27(19):4578\u201381.","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"1916_CR79","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1080\/14756366.2017.1344982","volume":"32","author":"C-F Liu","year":"2017","unstructured":"Liu C-F, Shen Q-K, Li J-J, Tian Y-S, Quan Z. Synthesis and biological evaluation of novel 7-hydroxy-4-phenylchromen-2-one\u2013linked to triazole moieties as potent cytotoxic agents. J Enzyme Inhib Med Chem. 2017;32(1):1111\u20139.","journal-title":"J Enzyme Inhib Med Chem"},{"key":"1916_CR80","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ejmech.2017.03.024","volume":"132","author":"T Abdizadeh","year":"2017","unstructured":"Abdizadeh T, Kalani MR, Abnous K, Tayarani-Najaran Z, Khashyarmanesh BZ, Abdizadeh R, et al. Design, synthesis and biological evaluation of novel coumarin-based benzamides as potent histone deacetylase inhibitors and anticancer agents. Eur J Med Chem. 2017;132:42\u201362.","journal-title":"Eur J Med Chem"},{"key":"1916_CR81","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.ejmech.2016.08.062","volume":"124","author":"TG Kraljevi\u0107","year":"2016","unstructured":"Kraljevi\u0107 TG, Harej A, Sedi\u0107 M, Paveli\u0107 SK, Stepani\u0107 V, Drenjan\u010devi\u0107 D, et al. Synthesis, in vitro anticancer and antibacterial activities and in silico studies of new 4-substituted 1, 2, 3-triazole\u2013coumarin hybrids. Eur J Med Chem. 2016;124:794\u2013808.","journal-title":"Eur J Med Chem"},{"key":"1916_CR82","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.ejmech.2012.06.050","volume":"54","author":"E Goffin","year":"2012","unstructured":"Goffin E, Lamoral-Theys D, Tajeddine N, De Tullio P, Mondin L, Lefranc F, et al. N-Aryl-N\u2032-(chroman-4-yl) ureas and thioureas display in vitro anticancer activity and selectivity on apoptosis-resistant glioblastoma cells: screening, synthesis of simplified derivatives, and structure-activity relationship analysis. Eur J Med Chem. 2012;54:834\u201344.","journal-title":"Eur J Med Chem"},{"issue":"15","key":"1916_CR83","doi-asserted-by":"publisher","first-page":"6738","DOI":"10.1021\/jm300752n","volume":"55","author":"J Mun","year":"2012","unstructured":"Mun J, Jabbar AA, Devi NS, Yin S, Wang Y, Tan C, et al. Design and in vitro activities of N-alkyl-N-[(8-R-2, 2-dimethyl-2 H-chromen-6-yl) methyl] heteroarylsulfonamides, novel, small-molecule hypoxia inducible factor-1 pathway inhibitors and anticancer agents. J Med Chem. 2012;55(15):6738\u201350.","journal-title":"J Med Chem"},{"issue":"8","key":"1916_CR84","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.2174\/1871520615666150101125503","volume":"15","author":"M Kaur","year":"2015","unstructured":"Kaur M, Kohli S, Sandhu S, Bansal Y, Bansal G. Coumarin: a promising scaffold for anticancer agents. AntiCancer Agents Med Chem. 2015;15(8):1032\u201348.","journal-title":"AntiCancer Agents Med Chem"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-022-01916-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-022-01916-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-022-01916-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T09:20:54Z","timestamp":1701508854000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-022-01916-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,5]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["1916"],"URL":"https:\/\/doi.org\/10.1007\/s12032-022-01916-4","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,5]]},"assertion":[{"value":"10 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"41"}}